In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Why Are People Injecting Themselves with Peptides? The New Yorker Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences